Evaluating whole‐brain tissue‐property changes in MRI‐negative pharmacoresistant focal epilepsies using MR fingerprinting is a dataset published in Epilepsia (2022). On theSindex it has a DataRank of 0.575, placing it in the top 34.1% of the data-sharing corpus. It has been cited 22 times, with 1 citing works in its 1-hop citation network.
Ranks in the top 34% for downstream scientific impact
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.470
From this paper's citation signal
Citation Network Contribution
0.105
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 1 citer.
National Institutes of Health
Grant: R01 NS109439
National Institutes of Health
Grant: R21 EB026764
National Institutes of Health
Grant: 5R21EB026764-02
A Framework to Design 3D Quantitative Magnetic Resonance Fingerprinting (MRF) Scans and Reduce Patient Anxiety
National Institutes of Health
Grant: 1R01NS109439-01
MR Fingerprinting for Epilepsy
FWCI
0.00
Citation Percentile
0.0%
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals